OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9480	Companies
185559	Keywords
117951	Articles
99390	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 05/20/2025 at 18:00, 6 months 16 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding shareholding percentages falling below thresholds. Atlas Special Opportunities II LLC sold voting securities affecting percentages. Visit www.oxurion.com for more info

Belgium Oxurion NV Transparency Notifications Shareholding Percentages Biofarmaceutical Company
PRESS RELEASE

published on 05/20/2025 at 18:00, 6 months 16 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding changes in share ownership per Belgian Transparency legislation. Oxurion is a biopharmaceutical company developing ophthalmic therapies

Biopharmaceutical Share Ownership Ophthalmic Therapies Oxurion NV Transparency Notifications
BRIEF

published on 05/16/2025 at 08:35, 6 months 20 days ago

Oxurion to Acquire Majority Stake in Axiodis CRO

Acquisition Revenue Growth Oxurion Axiodis CRO Clinical Biometrics
BRIEF

published on 05/16/2025 at 08:35, 6 months 20 days ago

Oxurion va acquérir une participation majoritaire dans Axiodis CRO

Acquisition Croissance Des Revenus Oxurion Axiodis CRO Biométrie Clinique
PRESS RELEASE

published on 05/16/2025 at 08:30, 6 months 20 days ago

Oxurion kondigt de ondertekening aan van een bindende overeenkomst tot overname van de Franse biometriespecialist Axiodis CRO
Oxurion NV erwirbt 72% des Aktienkapitals von Axiodis CRO für 468.000 EUR, um das Unternehmen auf 650.000 EUR zu bewerten. Transaktionsschluss erwartet bis Ende Juni 2025

Übernahme Transaktion Oxurion NV Axiodis CRO Aktienkapital
PRESS RELEASE

published on 05/16/2025 at 08:30, 6 months 20 days ago

Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO
Oxurion NV to acquire 72% of Axiodis CRO shares for €468,000, valuing the company at €650,000. Deal expected to close by June 2025. Axiodis CRO specializes in clinical biometrics, offers integrated services for clinical trials, and aims for revenue growth

Acquisition Revenue Growth Oxurion NV Axiodis CRO Clinical Biometrics
PRESS RELEASE

published on 05/16/2025 at 08:30, 6 months 20 days ago

Oxurion annonce la signature de l'accord ferme d'acquisition du français Axiodis CRO, spécialiste français de la biométrie
Oxurion NV acquiert 72% d'Axiodis CRO, une CRO spécialisée en biométrie clinique. Axiodis CRO prévoit un CA de 970K€ en 2025 et vise 2M€ en 2027

Chiffre D'affaires Acquisition Oxurion NV Axiodis CRO Biométrie Clinique
BRIEF

published on 05/15/2025 at 18:05, 6 months 21 days ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Acquisition Actions Transparence Atlas Special Opportunities Oxurion
BRIEF

published on 05/15/2025 at 18:05, 6 months 21 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Acquisition Actions Transparency Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/15/2025 at 18:00, 6 months 21 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notifications regarding changes in shareholding percentages to comply with Belgian transparency legislation. Details in attached PDF file

Shareholding Oxurion NV Belgian Legislation Transparency Notifications PDF File

Accesswire

Published on 12/05/2025 at 21:45, 1 hour 5 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 1 hour 20 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 1 hour 30 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 50 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 2 hours 25 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 35 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 38 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 3 hours 52 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 4 hours 24 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 4 hours 35 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 17:18, 5 hours 32 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 5 hours 32 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 7 hours 39 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 7 hours 39 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 52 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE